Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1995 Aug;69(8):5177–5185. doi: 10.1128/jvi.69.8.5177-5185.1995

Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.

G W Anderson 1, R R Rowland 1, G A Palmer 1, C Even 1, P G Plagemann 1
PMCID: PMC189342  PMID: 7609091

Abstract

Lactate dehydrogenase-elevating virus (LDV) replicates primarily and most likely solely in a subpopulation of macrophages in extraneuronal tissues. Infection of mice, regardless of age, with LDV leads to the rapid cytocidal replication of the virus in these cells, resulting in the release of large amounts of LDV into the circulation. The infection then progresses into life-long, asymptomatic, low-level viremic persistence, which is maintained by LDV replication in newly generated LDV-permissive cells which escapes all antiviral immune responses. In situ hybridization studies of tissue sections of adult FVB mice revealed that by 1 day postinfection (p.i.), LDV-infected cells were present in practically all tissues but were present in the highest numbers in the lymph nodes, spleen, and skin. In the central nervous system, LDV-infected cells were restricted to the leptomeninges. Most of the infected cells had disappeared at 3 days p.i., consistent with the cytocidal nature of the LDV infection, except for small numbers in lymph node, spleen, liver, and testis tissues. These tissues harbored infected cells until at least 90 days p.i. The results suggest that the generation of LDV-permissive cells during the persistent phase is restricted to these tissues. The continued presence of LDV-infected cells in testis tissue suggests the possibility of LDV release in semen and sexual transmission. Most striking was the accumulation of large amounts of LDV RNA in newly generated germinal centers of lymph nodes and the spleen. The LDV RNA was not associated with infected cells but was probably associated with virions or debris of infected, lysed cells. The appearance of LDV RNA in germinal centers in these mice coincided in time with the polyclonal activation of B cells, which leads to the accumulation of polyclonal immunoglobulin G2a and low-molecular-weight immune complexes in the circulation.

Full Text

The Full Text of this article is available as a PDF (4.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G. W., Palmer G. A., Rowland R. R., Even C., Plagemann P. G. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol. 1995 Jan;69(1):308–319. doi: 10.1128/jvi.69.1.308-319.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson G. W., Palmer G. A., Rowland R. R., Even C., Plagemann P. G. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons. J Gen Virol. 1995 Mar;76(Pt 3):581–592. doi: 10.1099/0022-1317-76-3-581. [DOI] [PubMed] [Google Scholar]
  3. Blum H. E., Haase A. T., Vyas G. N. Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet. 1984 Oct 6;2(8406):771–775. doi: 10.1016/s0140-6736(84)90703-7. [DOI] [PubMed] [Google Scholar]
  4. Brinton-Darnell M., Plagemann P. G. Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J Virol. 1975 Aug;16(2):420–433. doi: 10.1128/jvi.16.2.420-433.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cafruny W. A., Chan S. P., Harty J. T., Yousefi S., Kowalchyk K., McDonald D., Foreman B., Budweg G., Plagemann P. G. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res. 1986 Sep;5(4):357–375. doi: 10.1016/0168-1702(86)90029-8. [DOI] [PubMed] [Google Scholar]
  6. Cafruny W. A., Hovinen D. E. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies. J Gen Virol. 1988 Mar;69(Pt 3):723–729. doi: 10.1099/0022-1317-69-3-723. [DOI] [PubMed] [Google Scholar]
  7. Cafruny W. A., Hovinen D. E. The relationship between route of infection and minimum infectious dose: studies with lactate dehydrogenase-elevating virus. J Virol Methods. 1988 Jul;20(3):265–268. doi: 10.1016/0166-0934(88)90129-2. [DOI] [PubMed] [Google Scholar]
  8. Chen Z., Kuo L., Rowland R. R., Even C., Faaberg K. S., Plagemann P. G. Sequences of 3' end of genome and of 5' end of open reading frame 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5' leader and bodies of seven subgenomic mRNAs. J Gen Virol. 1993 Apr;74(Pt 4):643–659. doi: 10.1099/0022-1317-74-4-643. [DOI] [PubMed] [Google Scholar]
  9. Clark E. A., Ledbetter J. A. How B and T cells talk to each other. Nature. 1994 Feb 3;367(6462):425–428. doi: 10.1038/367425a0. [DOI] [PubMed] [Google Scholar]
  10. Coutelier J. P., Coulie P. G., Wauters P., Heremans H., van der Logt J. T. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol. 1990 Nov;64(11):5383–5388. doi: 10.1128/jvi.64.11.5383-5388.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coutelier J. P., Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol. 1985 Mar;15(3):250–255. doi: 10.1002/eji.1830150308. [DOI] [PubMed] [Google Scholar]
  12. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993 Mar 25;362(6418):359–362. doi: 10.1038/362359a0. [DOI] [PubMed] [Google Scholar]
  13. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993 Nov 12;262(5136):1011–1018. doi: 10.1126/science.8235617. [DOI] [PubMed] [Google Scholar]
  14. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
  15. Hodgkin P. D., Basten A. B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol. 1995 Feb;7(1):121–129. doi: 10.1016/0952-7915(95)80037-9. [DOI] [PubMed] [Google Scholar]
  16. Inada T., Mims C. A. Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Arch Virol. 1985;86(3-4):151–165. doi: 10.1007/BF01309821. [DOI] [PubMed] [Google Scholar]
  17. King W. W., St Amant L. G., Lee W. R. A technique for serial spermatozoa collection in mice. Lab Anim Sci. 1994 Jun;44(3):295–296. [PubMed] [Google Scholar]
  18. Koup R. A., Ho D. D. Shutting down HIV. Nature. 1994 Aug 11;370(6489):416–416. doi: 10.1038/370416a0. [DOI] [PubMed] [Google Scholar]
  19. Li X., Hu B., Harty J., Even C., Plagemann P. G. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes. Viral Immunol. 1990 Winter;3(4):273–288. doi: 10.1089/vim.1990.3.273. [DOI] [PubMed] [Google Scholar]
  20. Onyekaba C. O., Harty J. T., Even C., Hu B. G., Plagemann P. G. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res. 1989 Dec;14(4):297–315. doi: 10.1016/0168-1702(89)90023-3. [DOI] [PubMed] [Google Scholar]
  21. Plagemann P. G., Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res. 1992;41:99–192. doi: 10.1016/S0065-3527(08)60036-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Porter D. D., Porter H. G., Deerhake B. B. Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. J Immunol. 1969 Feb;102(2):431–436. [PubMed] [Google Scholar]
  23. Rowland R. R., Even C., Anderson G. W., Chen Z., Hu B., Plagemann P. G. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. J Gen Virol. 1994 May;75(Pt 5):1071–1081. doi: 10.1099/0022-1317-75-5-1071. [DOI] [PubMed] [Google Scholar]
  24. Rowson K. E., Mahy B. W. Lactate dehydrogenase-elevating virus. J Gen Virol. 1985 Nov;66(Pt 11):2297–2312. doi: 10.1099/0022-1317-66-11-2297. [DOI] [PubMed] [Google Scholar]
  25. Snodgrass M. J., Hanna M. G., Jr Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue. 3. Alterations in the thymic-dependent area induced by the passenger lactic dehydrogenase virus. J Natl Cancer Inst. 1970 Oct;45(4):741–759. [PubMed] [Google Scholar]
  26. Timoney P. J., McCollum W. H. Equine viral arteritis. Vet Clin North Am Equine Pract. 1993 Aug;9(2):295–309. doi: 10.1016/S0749-0739(17)30397-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
  28. Weiland E., Weiland F., Grossmann A. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies. J Gen Virol. 1987 Jul;68(Pt 7):1983–1991. doi: 10.1099/0022-1317-68-7-1983. [DOI] [PubMed] [Google Scholar]
  29. de Vries A. A., Chirnside E. D., Horzinek M. C., Rottier P. J. Structural proteins of equine arteritis virus. J Virol. 1992 Nov;66(11):6294–6303. doi: 10.1128/jvi.66.11.6294-6303.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES